Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28668146 | 1.00 | CYP3A4 (0.48) | CYP3A4HTTMEN1THRBKMT2A | |
| SCHEMBL30198860 | 0.98 | HTT (0.52) | CYP3A4HTTMEN1THRBKMT2A | |
| SCHEMBL30585300 | 0.95 | HTT (0.54) | CYP3A4HTTMEN1THRBKMT2A | |
| SCHEMBL30198787 | 0.95 | HTT (0.54) | CYP3A4HTTMEN1THRBKMT2A | |
| SCHEMBL9218954 | 0.95 | HTT (0.54) | CYP3A4HTTMEN1THRBKMT2A | |
| SCHEMBL31188608 | 0.95 | HTT (0.54) | CYP3A4HTTMEN1THRBKMT2A | |
| SCHEMBL1734748 | 0.95 | HTT (0.54) | CYP3A4HTTMEN1THRBKMT2A | |
| SCHEMBL1734657 | 0.93 | HTT (0.58) | CYP3A4HTTMEN1THRBKMT2A | |
| SCHEMBL30198788 | 0.91 | HTT (0.50) | CYP3A4HTTMEN1THRBKMT2A | |
| SCHEMBL25730130 | 0.91 | HTT (0.56) | CYP3A4HTTMEN1THRBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114901690-A | Treatment of cancer with Antibody Drug Conjugates (ADCs) that bind 191P4D12 protein | 艾更斯司股份有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-113677364-A | Pharmaceutical compositions comprising anti-191P 4D12 antibody drug conjugates and methods of use thereof | 艾更斯司股份有限公司 | 2021-11-19 | — | — | CN | disclosed |